Mint-Citalopram Solution: Uses, Side Effects and Dosage

Serious warnings and precautions box

Self-harm or suicide:

• Antidepressants, such as MINT-CITALOPRAM SOLUTION, may increase the risk of suicidal thoughts and actions in some children, teenagers, or young adults at the beginning of treatment, or when the dose is changed. MINT-CITALOPRAM SOLUTION is not approved for use in children and teenagers.
• If you have thoughts of harming or killing yourself at any time, tell your healthcare professional or go to a hospital right away. Close observation by a healthcare professional is necessary in this situation.

New or worsened emotional or behavioural problems:

• When you first start taking MINT-CITALOPRAM SOLUTION or when your dose is adjusted, you may feel worse instead of better. You may feel new or worsened feelings of agitation, hostility, anxiety, or impulsivity.
• During your treatment with MINT-CITALOPRAM SOLUTION, it is important that you and your healthcare professional talk regularly about how you are feeling. They will closely monitor you for signs of new or worsened emotions or behaviours while you are taking MINT-CITALOPRAM SOLUTION.

• You may find it helpful to tell a relative or close friend that you are depressed. Ask them to read this leaflet. You might ask them to tell you if they:

  • think your depression is getting worse, or
  • are worried about changes in your behaviour.
• If your depression worsens or you experience changes in your behaviour, tell your healthcare professional right away. Do not stop taking MINT-CITALOPRAM SOLUTION on your own.

What MINT-CITALOPRAM SOLUTION is used for:

MINT-CITALOPRAM SOLUTION is used to relieve the symptoms of depression in adults. Your healthcare professional will keep evaluating if MINT-CITALOPRAM SOLUTION is still safe and effective for you if you take it for a long time.

How MINT-CITALOPRAM SOLUTION works:

MINT-CITALOPRAM SOLUTION is known as an antidepressant and belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs).

MINT-CITALOPRAM SOLUTION works by increasing the levels of a chemical in the brain called serotonin.

The ingredients in MINT-CITALOPRAM SOLUTION are:

Medicinal ingredients: citalopram hydrobromide

Non-medicinal ingredients: anhydrous citric acid, natural peppermint flavour, non crystallizing sorbitol solution, propyl paraben, propylene glycol, methyl paraben, purified water.

MINT-CITALOPRAM SOLUTION comes in the following dosage form(s):

As an oral solution containing 2 mg/ mL of citalopram (as citalopram hydrobromide).

Do not use MINT-CITALOPRAM SOLUTION if:

• you are allergic to citalopram hydrobromide or escitalopram oxalate.
• you are allergic to any of the other ingredients in MINT-CITALOPRAM SOLUTION or to a component of the container.
• you are also taking the medicine pimozide, used to treat schizophrenia.
• you are currently taking or have taken, within 14 days, medicines called monoamine oxidase antidepressants such as phenelzine sulphate, tranylcypromine or moclobemide, or other monoamine oxidase inhibitors such as linezolid, methylene blue, selegiline.
• you have been told that you have QT interval prolongation (abnormal electrical activity of the heart) or have been diagnosed with a condition called a congenital long QT syndrome.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MINT-CITALOPRAM SOLUTION. Talk about any health conditions or problems you may have, including if you:

• have heart problems.
• have diabetes. MINT-CITALOPRAM SOLUTION may make it more difficult to control your blood sugar.
• have liver or kidney problems.
• have or have had a seizure disorder.
• have or have had manic episodes or have been diagnosed with bipolar disorder.
• are receiving electroconvulsive therapy.
• have a bleeding disorder or have been told that you have low platelets.
• have a family history of QT/QTc prolongation (abnormal electrical activity of the heart).
• have electrolyte disturbances like low blood potassium, magnesium, or calcium levels or conditions that could lead to this such as vomiting, diarrhea, dehydration.
• had a recent bone fracture or were told you have osteoporosis or risk factors for osteoporosis.
• are taking other antidepressants, triptans used to treat migraines, lithium, opioids (including to treat pain, or drug dependence), or drugs containing tryptophan.
• have habits of alcohol and /or street drug consumption.
• are taking St. John’s Wort, an herbal product used to treat depression.

Other warnings you should know about:

• It is important that you and your healthcare professional talk regularly about how you are feeling while you are taking MINT-CITALOPRAM SOLUTION.

• MINT-CITALOPRAM SOLUTION should not be used in children and adolescents under 18 years of age.

Activation of Mania: Tell your healthcare professional if you have or have had manic episodes in the past or if you have been diagnosed with bipolar disorder. MINT-CITALOPRAM SOLUTION should be used with caution if you have a history of manic episodes. Some patients with bipolar disorder (also known as manic depression) may enter into a manic phase when they start taking MINT-CITALOPRAM SOLUTION. Tell your healthcare professional if you experience symptoms of mania such as excessive physical activity, overactive behaviour or thoughts, increased energy, trouble sleeping, racing thoughts, reckless behaviour, excessive happiness or irritability, talking more or faster than usual.

Bleeding Problems: Before taking MINT-CITALOPRAM SOLUTION tell your healthcare professional if you have a bleeding disorder including low blood platelets. Drugs from the class that MINT-CITALOPRAM SOLUTION belongs to may increase the chance of a bleeding event such as nose bleeds, bruising and even life threatening bleeding. This is more likely if you have a history of a bleeding disorder or are taking other drugs that are known to affect blood clotting. Talk to your healthcare professional about drugs that might increase bleeding.

Pregnancy: Before taking MINT-CITALOPRAM SOLUTION, tell your healthcare professional if you are pregnant, think you might be pregnant or are planning to become pregnant. You should not take MINT-CITALOPRAM SOLUTION if you are pregnant unless you and your healthcare professional have discussed the risks and decided that you should. Tell your healthcare professional right away if you become pregnant while taking MINT-CITALOPRAM SOLUTION. If you take MINT-CITALOPRAM SOLUTION near the end of your pregnancy, you could have heavy vaginal bleeding shortly after giving birth.

Effects on Newborns: Some newborn babies whose mothers took medications such as MINT-CITALOPRAM SOLUTION during pregnancy have developed problems at birth. These problems include prolonged hospitalisation, breathing support and tube feeding. Symptoms can include:

• feeding and/or breathing difficulties
• bluish skin
• seizures
• body temperature changes
• vomiting
• low blood sugar
• tense or overly relaxed muscles
• vivid reflexes
• tremor
• jitteriness
• irritability
• sleeping difficulties and
• constant crying.

In most cases, these medications were taken during the third trimester of pregnancy. These symptoms are caused by the medication itself or from the effects of suddenly stopping the medication. These symptoms normally go away over time. However, if your baby experiences any of these symptoms, contact your healthcare professional as soon as you can.

Persistent Pulmonary Hypertension of the Newborn (PPHN): If you take MINT-CITALOPRAM SOLUTION towards the end of your pregnancy, your newborn may be at risk of having a serious lung condition called Persistent Pulmonary Hypertension of the Newborn (PPHN). This causes breathing problems in newborns soon after birth. Newborn babies may breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your newborn baby, get immediate medical help for them.

Breastfeeding: Tell your healthcare professional if you are breastfeeding or planning to breastfeed. MINT-CITALOPRAM SOLUTION is released into breast milk. It is not known if this is safe for your baby. You should not breastfeed a baby if you are taking MINT-CITALOPRAM SOLUTION unless you and your healthcare professional have discussed the risks and decided that you should.

Effect on the electrical activity of the heart: MINT-CITALOPRAM SOLUTION has an effect on the electrical activity of the heart known as QT/QTc prolongation (abnormal electrical activity of the heart). This can lead to disturbances in heart rhythm (arrhythmias/dysrhythmias) that could result in dizziness, palpitations (sensation of rapid, pounding, or irregular heart beat), fainting or cardiac arrest and death. This is more likely in patients with risk factors, such as heart disease, heart attack, or in the presence of certain drugs that could interact with the activity of the heart. If you experience any symptoms of a possible heart rhythm disturbance (abnormal heart rate or rhythm), such as dizziness, palpitations (sensation of rapid, pounding, or irregular heart beat), fainting, or seizures, you should seek immediate medical attention.

Serotonin Toxicity or Neuroleptic malignant syndrome: Serotonin toxicity (also known as Serotonin syndrome): MINT-CITALOPRAM SOLUTION can cause Serotonin toxicity, a rare but potentially life- threatening condition. It can cause serious changes in how your brain, muscles and digestive system work. You may develop Serotonin toxicity if you take MINT-CITALOPRAM SOLUTION with certain anti- depressants or migraine medications.

Serotonin toxicity or Neuroleptic malignant syndrome symptoms include:

• fever, sweating, shivering, diarrhea, nausea, vomiting;
• muscle shakes, jerks, twitches or stiffness, overactive reflexes, loss of coordination
• fast heartbeat, changes in blood pressure;
• confusion, agitation, restlessness, hallucinations, mood changes, unconsciousness, and coma

Effects on Sexual Function: Taking medicines like MINT-CITALOPRAM SOLUTION may cause symptoms of sexual dysfunction. In some cases these symptoms have continued after stopping MINT-CITALOPRAM SOLUTION treatment. Talk to your healthcare professional if you experience symptoms such as a decrease in sexual desire, performance or satisfaction.

Risk of Bone Fractures: Taking MINT-CITALOPRAM SOLUTION may increase your risk of breaking a bone if you are elderly, have osteoporosis or other risk factors for breaking a bone. You should take extra care to avoid falls especially if you get dizzy or have low blood pressure.

Angle-closure Glaucoma: MINT-CITALOPRAM SOLUTION can cause dilation of the pupil. This may cause an acute glaucoma attack in an individual with narrow ocular angles. Having your eyes examined before you take MINT-CITALOPRAM SOLUTION could help identify if you are at risk of having angle-closure glaucoma. Get immediate medical help if you experience:

• eye pain
• changes in vision
• swelling or redness in or around the eye.

Driving and using machines: MINT-CITALOPRAM SOLUTION may impair your ability to drive or to use machines. Wait until you know how MINT-CITALOPRAM SOLUTION affects you before driving or using machines. Do not drive or use machines if MINT-CITALOPRAM SOLUTION impairs your ability to do so safely.

Discontinuation Symptoms: Contact your healthcare professional before stopping or reducing your dosage of MINT-CITALOPRAM SOLUTION. If you stop or reduce the dosage of MINT-CITALOPRAM SOLUTION abruptly, or if you miss a dose, you may experience symptoms such as dizziness, sleep disturbances, abnormal dreams, sensory disturbance like electric shock sensations, agitation, anxiety, headache, tremor (shakiness), nausea, vomiting. Tell your healthcare professional immediately if you have these or any other symptoms. Your healthcare professional may adjust the dosage of MINT-CITALOPRAM SOLUTION to reduce the symptoms.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug Interactions:

Serious drug interactions with MINT-CITALOPRAM SOLUTION include:

• Monoamine oxidase inhibitors such as phenelzine, tranylcypromine, moclobemide or selegiline, linezolid (as antibiotic) or Methylene blue (intravenous). Do not use MINT-CITALOPRAM SOLUTION if you are taking a MAOI, or have recently taken one in the last 14 days.
• Pimozide

The following may also interact with MINT-CITALOPRAM SOLUTION:

• drugs to treat heart rhythm disturbances (antiarrhythmics)
• antipsychotics, used to treat schizophrenia
• opioids (including for pain, drug dependence or anesthesia) such as methadone, buprenorphine, tramadol, fentanyl, tapentadol, meperidine or pentazocine
• drugs to treat infections
• drugs to treat nausea and vomiting
• cancer drugs
• asthma drugs
• diuretics (water pills)
• carbamazepine, used to treat seizures
• other SSRIs e.g., Cipralex^® (escitalopram) or any other antidepressant (e.g., imipramine, desipramine)
• lithium, used to treat mood disorder
• tryptophan, for sleep aid or treating anxiety
• cimetidine, for acidity problems
• triptans (e.g., sumatriptan, zolmitriptan, naratriptan), for Migraine
• fluconazole, Ketoconazole, Itraconazole, for treating fungal infection
• erythromycin, used to treat infections
• warfarin, used to prevent clot of blood
• omeprazole, used to treat stomach problems
• any herbal product such as St. John’s Wort
• certain medicines which may affect blood clotting and increase bleeding, such as oral anticoagulants (e.g., warfarin, dabigatran), acetylsalicyIic acid (e.g., Aspirin^®) and other non- steroidal anti-inflammatory drugs (ibuprofen)
• certain medicines used to treat cough, such as dextromethorphan

Avoid drinking alcohol while taking MINT-CITALOPRAM SOLUTION.

How to take MINT-CITALOPRAM SOLUTION:

• Take MINT-CITALOPRAM SOLUTION exactly as your doctor has told you.

• You can take MINT-CITALOPRAM SOLUTION with or without food.

• Take MINT-CITALOPRAM SOLUTION once a day at the same time every day.
• Continue taking MINT-CITALOPRAM SOLUTION even if you do not feel better. It may take several weeks for it to work and improvement may be gradual.
• Keep taking MINT-CITALOPRAM SOLUTION for as long as your healthcare professional recommends. Do not stop taking MINT-CITALOPRAM SOLUTION abruptly even if you feel better unless your doctor has told you to.
• Never take more MINT-CITALOPRAM SOLUTION than your doctor has prescribed for you.
• Follow all instructions given to you by your healthcare professional.

Usual dose:

The usual dose is 20 mg once a day. Your healthcare professional might prescribe a lower dose if you are elderly, have liver problems or in other situations.

Overdose:

If you think you, or a person you are caring for, have taken too MINT-CITALOPRAM SOLUTION, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed dose:

If you forget a dose, take the next dose as planned. Do not take a double dose to make up for a forgotten dose.

Possible side effects from using MINT-CITALOPRAM SOLUTION:

These are not all the possible side effects you may have when taking MINT-CITALOPRAM SOLUTION. If you experience any side effects not listed here, tell your healthcare professional.

Side effects may include:

• Fatigue
• Dry mouth
• Increased sweating
• Tremor (shakiness)
• Nausea
• Diarrhea
• Somnolence (sleepiness)
• Ejaculation disorder

Serious side effects and what to do about them

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

• Visiting the Web page on Adverse Reaction Reporting (www.canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
• Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store MINT-CITALOPRAM SOLUTION at room temperature (15 - 30°C) in its original packaging, protect from light.

Keep out of the reach and sight of children.

If you want more information about MINT-CITALOPRAM SOLUTION:

• Talk to your healthcare professional
• Find the full product monograph that is prepared for healthcare professionals and includes the Patient Medication Information by visiting the Health Canada Drug Product Database website (https://health-products.canada.ca/dpd-bdpp); the manufacturer’s website www.mintpharma.com, or by calling 1-877-398-9696.

Last Revised 2026-02-25